BIO-INVEST: what changed
BIO-INVEST
Largest movements
- Cash +€120,878
up €120,878 (+10.3%), from €1.2m to €1.3m
mainly Net result for the year (+€128,860) and Receivables within one year (+€1,374)
- Reserves +€128,860
up €128,860 (+9.6%), from €1.3m to €1.5m
of which Distributable reserves: +€128,860
- Gross operating margin -€41,469
down €41,469 (-19.4%), from €214,152 to €172,683
- Staff costs -€11,674
down €11,674, from €11,655 to -€18
- Taxes -€8,316
down €8,316 (-16.2%), from €51,269 to €42,953
Change in the result, 2025 to 2026
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,497,288 | €1,616,840 | +€119,553 | +8.0% |
| Fixed assets | 21/28 | €122,274 | €122,274 | = | 0.0% |
| Financial fixed assets | 28 | €122,274 | €122,274 | = | 0.0% |
| Current assets | 29/58 | €1,375,014 | €1,494,567 | +€119,553 | +8.7% |
| Amounts receivable within one year | 40/41 | €198,674 | €197,300 | -€1,374 | -0.7% |
| Trade receivables | 40 | €18,079 | €14,987 | -€3,092 | -17.1% |
| Other amounts receivable | 41 | €180,595 | €182,313 | +€1,718 | +1.0% |
| Cash at bank and in hand | 54/58 | €1,176,340 | €1,297,219 | +€120,878 | +10.3% |
| Deferred charges and accrued income | 490/1 | €0 | €48 | +€48 | |
| Total equity and liabilities | 10/49 | €1,497,288 | €1,616,840 | +€119,553 | +8.0% |
| Equity | 10/15 | €1,465,540 | €1,594,400 | +€128,860 | +8.8% |
| Contributions | 10/11 | €125,000 | €125,000 | = | 0.0% |
| Reserves | 13 | €1,340,540 | €1,469,400 | +€128,860 | +9.6% |
| Non-distributable reserves | 130/1 | €12,500 | €12,500 | = | 0.0% |
| Reserves not available under the articles | 1311 | €12,500 | €12,500 | = | 0.0% |
| Distributable reserves | 133 | €1,328,040 | €1,456,900 | +€128,860 | +9.7% |
| Amounts payable | 17/49 | €31,747 | €22,440 | -€9,307 | -29.3% |
| Amounts payable within one year | 42/48 | €29,754 | €20,658 | -€9,096 | -30.6% |
| Trade debts | 44 | €0 | - | = | |
| Suppliers | 440/4 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €20,635 | €11,350 | -€9,285 | -45.0% |
| Taxes | 450/3 | €20,635 | €11,350 | -€9,285 | -45.0% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €9,119 | €9,308 | +€190 | +2.1% |
| Accrued charges and deferred income | 492/3 | €1,993 | €1,782 | -€211 | -10.6% |
| Remuneration, social security and pensions | 62 | €11,655 | -€18 | -€11,674 | |
| Other operating charges | 640/8 | €1,268 | €1,311 | +€43 | +3.4% |
| Gross operating margin | 9900 | €214,152 | €172,683 | -€41,469 | -19.4% |
| Operating profit (loss) | 9901 | €201,229 | €171,391 | -€29,838 | -14.8% |
| Financial income | 75/76B | €1,788 | €1,800 | +€12 | +0.6% |
| Recurring financial income | 75 | €1,788 | €1,800 | +€12 | +0.6% |
| Financial charges | 65/66B | €1,303 | €1,377 | +€74 | +5.7% |
| Recurring financial charges | 65 | €1,303 | €1,377 | +€74 | +5.7% |
| Profit (loss) for the period before taxes | 9903 | €201,714 | €171,813 | -€29,901 | -14.8% |
| Income taxes | 67/77 | €51,269 | €42,953 | -€8,316 | -16.2% |
| Profit (loss) for the period | 9904 | €150,445 | €128,860 | -€21,585 | -14.3% |
| Profit (loss) for the period to be appropriated | 9905 | €150,445 | €128,860 | -€21,585 | -14.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.